Skip to main content
Top
Published in: Cancer Cell International 1/2020

Open Access 01-12-2020 | Acute Myeloid Leukemia | Primary research

Association between TERT gene polymorphisms and acute myeloid leukemia susceptibility in a Chinese population: a case–control study

Authors: Yong Tong, Yinzhou Xiang, Bao Li, Shijie Bao, Ying Zhou, Wen Yuan, Yu Ling, Dan Hao, Huamin Zhu, Zhiqiang Sun

Published in: Cancer Cell International | Issue 1/2020

Login to get access

Abstract

Background

The aim of this study was to investigate the association between telomerase reverse transcriptase (TERT) gene polymorphisms and acute myeloid leukemia (AML) susceptibility in a Chinese Han population.

Methods

A total of 102 AML patients and 108 healthy controls were enrolled in this case–control study. TERT gene rs2853669 and rs2736100 polymorphisms were genotyped via polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Chi-square test was applied to compare polymorphism distributions between case and control groups. The strength of the association between TERT gene polymorphisms and AML susceptibility was evaluated utilizing odds ratio (OR) with corresponding 95% confidence interval (CI).

Results

CC genotype and C allele of rs2736100 polymorphism were more frequent in AML patients (P < 0.05), and individuals carrying CC genotype showed higher risk of suffering from AML (OR = 2.632, 95% CI 1.129–6.133). But for rs2853669 polymorphism, no significant differences were detected in either genotype or allele distributions between groups (P > 0.05).

Conclusions

This study suggested a positive association between TERT gene rs2736100 polymorphism and AML susceptibility in Chinese Han population.
Literature
1.
go back to reference Mandegary A, Rostami S, Alimoghaddam K, Ghavamzadeh A, Ghahremani MH. Gluthatione-S-transferase T1-null genotype predisposes adults to acute promyelocytic leukemia; a case-control study. Asian Pac J Cancer Prev APJCP. 2011;12(5):1279–82.PubMed Mandegary A, Rostami S, Alimoghaddam K, Ghavamzadeh A, Ghahremani MH. Gluthatione-S-transferase T1-null genotype predisposes adults to acute promyelocytic leukemia; a case-control study. Asian Pac J Cancer Prev APJCP. 2011;12(5):1279–82.PubMed
2.
go back to reference Zaitseva L, Murray MY, Shafat MS, Lawes MJ, MacEwan DJ, Bowles KM, Rushworth SA. Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML. Oncotarget. 2014;5(20):9930–8.CrossRef Zaitseva L, Murray MY, Shafat MS, Lawes MJ, MacEwan DJ, Bowles KM, Rushworth SA. Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML. Oncotarget. 2014;5(20):9930–8.CrossRef
3.
go back to reference Khasawneh MK, Abdel-Wahab O. Recent discoveries in molecular characterization of acute myeloid leukemia. Curr Hematol Malig Rep. 2014;9(2):93–9.CrossRef Khasawneh MK, Abdel-Wahab O. Recent discoveries in molecular characterization of acute myeloid leukemia. Curr Hematol Malig Rep. 2014;9(2):93–9.CrossRef
4.
go back to reference Foran JM. New prognostic markers in acute myeloid leukemia: perspective from the clinic. Hematol Am Soc Hematol Educ Program. 2010;2010:47–55.CrossRef Foran JM. New prognostic markers in acute myeloid leukemia: perspective from the clinic. Hematol Am Soc Hematol Educ Program. 2010;2010:47–55.CrossRef
5.
go back to reference Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. 2013;381(9865):484–95.CrossRef Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. 2013;381(9865):484–95.CrossRef
6.
go back to reference O’Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, et al. Acute myeloid leukemia, version 2.2013. J Natl Compr Cancer Netw JNCCN. 2013;11(9):1047–55.CrossRef O’Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, et al. Acute myeloid leukemia, version 2.2013. J Natl Compr Cancer Netw JNCCN. 2013;11(9):1047–55.CrossRef
7.
go back to reference Fircanis S, Merriam P, Khan N, Castillo JJ. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies. Am J Hematol. 2014;89(8):E125–32.CrossRef Fircanis S, Merriam P, Khan N, Castillo JJ. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies. Am J Hematol. 2014;89(8):E125–32.CrossRef
8.
go back to reference Scarabino D, Broggio E, Gambina G, Pelliccia F, Corbo RM. Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimers disease. Exp Gerontol. 2017;88:19–24.CrossRef Scarabino D, Broggio E, Gambina G, Pelliccia F, Corbo RM. Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimers disease. Exp Gerontol. 2017;88:19–24.CrossRef
9.
go back to reference Ding D, Zhou J, Wang M, Cong YS. Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer. FEBS J. 2013;280(14):3205–11.CrossRef Ding D, Zhou J, Wang M, Cong YS. Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer. FEBS J. 2013;280(14):3205–11.CrossRef
10.
go back to reference Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstatter A, Kronenberg F, Kiechl S. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304(1):69–75.CrossRef Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstatter A, Kronenberg F, Kiechl S. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304(1):69–75.CrossRef
11.
go back to reference Zhang C, Doherty JA, Burgess S, Hung RJ, Lindstrom S, Kraft P, Gong J, Amos CI, Sellers TA, Monteiro AN, et al. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum Mol Genet. 2015;24(18):5356–66.CrossRef Zhang C, Doherty JA, Burgess S, Hung RJ, Lindstrom S, Kraft P, Gong J, Amos CI, Sellers TA, Monteiro AN, et al. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum Mol Genet. 2015;24(18):5356–66.CrossRef
12.
go back to reference Liu T, Yuan X, Xu D. Cancer-specific telomerase reverse transcriptase (TERT) promoter mutations: biological and clinical implications. Genes. 2016;7(7):38.CrossRef Liu T, Yuan X, Xu D. Cancer-specific telomerase reverse transcriptase (TERT) promoter mutations: biological and clinical implications. Genes. 2016;7(7):38.CrossRef
13.
go back to reference Mosrati MA, Willander K, Falk IJ, Hermanson M, Hoglund M, Stockelberg D, Wei Y, Lotfi K, Soderkvist P. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis. Oncotarget. 2015;6(28):25109–20.CrossRef Mosrati MA, Willander K, Falk IJ, Hermanson M, Hoglund M, Stockelberg D, Wei Y, Lotfi K, Soderkvist P. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis. Oncotarget. 2015;6(28):25109–20.CrossRef
14.
go back to reference Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292–302.CrossRef Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292–302.CrossRef
16.
go back to reference Godley LA, Cunningham J, Dolan ME, Huang RS, Gurbuxani S, McNerney ME, Larson RA, Leong H, Lussier Y, Onel K, et al. An integrated genomic approach to the assessment and treatment of acute myeloid leukemia. Semin Oncol. 2011;38(2):215–24.CrossRef Godley LA, Cunningham J, Dolan ME, Huang RS, Gurbuxani S, McNerney ME, Larson RA, Leong H, Lussier Y, Onel K, et al. An integrated genomic approach to the assessment and treatment of acute myeloid leukemia. Semin Oncol. 2011;38(2):215–24.CrossRef
17.
go back to reference Fonseka LN, Tirado CA. Telomerase in acute myeloid leukemia: a molecular update on diagnosis, prognosis, and treatment. J Assoc Genet Technol. 2016;42(3):105–10.PubMed Fonseka LN, Tirado CA. Telomerase in acute myeloid leukemia: a molecular update on diagnosis, prognosis, and treatment. J Assoc Genet Technol. 2016;42(3):105–10.PubMed
18.
go back to reference Calvello C, Rocca B, Klersy C, Zappatore R, Giardini I, Dambruoso I, Pasi F, Caresana M, Zappasodi P, Nano R, et al. Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia. Leuk Lymphoma. 2018;59(3):702–9.CrossRef Calvello C, Rocca B, Klersy C, Zappatore R, Giardini I, Dambruoso I, Pasi F, Caresana M, Zappasodi P, Nano R, et al. Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia. Leuk Lymphoma. 2018;59(3):702–9.CrossRef
19.
go back to reference Shay JW. Role of telomeres and telomerase in aging and cancer. Cancer Discov. 2016;6(6):584–93.CrossRef Shay JW. Role of telomeres and telomerase in aging and cancer. Cancer Discov. 2016;6(6):584–93.CrossRef
20.
go back to reference Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339(6122):957–9.CrossRef Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339(6122):957–9.CrossRef
21.
go back to reference Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013; 45(4):371–384, 384e371–372. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013; 45(4):371–384, 384e371–372.
22.
go back to reference Choi BJ, Yoon JH, Kim O, Choi WS, Nam SW, Lee JY, Park WS. Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer. World J Gastroenterol. 2015;21(31):9328–36.CrossRef Choi BJ, Yoon JH, Kim O, Choi WS, Nam SW, Lee JY, Park WS. Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer. World J Gastroenterol. 2015;21(31):9328–36.CrossRef
23.
go back to reference Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, Prescott J, De Vivo I, Nitti D. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012;104(11):840–54.CrossRef Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, Prescott J, De Vivo I, Nitti D. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012;104(11):840–54.CrossRef
24.
go back to reference Wei R, Cao L, Pu H, Wang H, Zheng Y, Niu X, Weng X, Zhang H, Favus M, Zhang L, et al. TERT polymorphism rs2736100-c is associated with EGFR mutation-positive non-small cell lung cancer. Clin Cancer Res. 2015;21(22):5173–80.CrossRef Wei R, Cao L, Pu H, Wang H, Zheng Y, Niu X, Weng X, Zhang H, Favus M, Zhang L, et al. TERT polymorphism rs2736100-c is associated with EGFR mutation-positive non-small cell lung cancer. Clin Cancer Res. 2015;21(22):5173–80.CrossRef
25.
go back to reference Savage SA, Chanock SJ, Lissowska J, Brinton LA, Richesson D, Peplonska B, Bardin-Mikolajczak A, Zatonski W, Szeszenia-Dabrowska N, Garcia-Closas M. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer. 2007;97(6):832–6.CrossRef Savage SA, Chanock SJ, Lissowska J, Brinton LA, Richesson D, Peplonska B, Bardin-Mikolajczak A, Zatonski W, Szeszenia-Dabrowska N, Garcia-Closas M. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer. 2007;97(6):832–6.CrossRef
26.
go back to reference Zhong R, Liu L, Zou L, Zhu Y, Chen W, Zhu B, Shen N, Rui R, Long L, Ke J, et al. Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population. Mol Carcinog. 2013;52(Suppl 1):E118–26.CrossRef Zhong R, Liu L, Zou L, Zhu Y, Chen W, Zhu B, Shen N, Rui R, Long L, Ke J, et al. Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population. Mol Carcinog. 2013;52(Suppl 1):E118–26.CrossRef
Metadata
Title
Association between TERT gene polymorphisms and acute myeloid leukemia susceptibility in a Chinese population: a case–control study
Authors
Yong Tong
Yinzhou Xiang
Bao Li
Shijie Bao
Ying Zhou
Wen Yuan
Yu Ling
Dan Hao
Huamin Zhu
Zhiqiang Sun
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-020-01335-3

Other articles of this Issue 1/2020

Cancer Cell International 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine